Clinical Trial Update: Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

View source ↗

Summary

A completed clinical trial evaluating genomic markers to measure response of breast cancer to neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Breast Cancer, Breast Neoplasms | Status: COMPLETED